FI103884B1 - Menetelmä farmaseuttisesti tehokkaiden guanidinokarbonyylisubstituoitujen isokinoliinien valmistamiseksi - Google Patents
Menetelmä farmaseuttisesti tehokkaiden guanidinokarbonyylisubstituoitujen isokinoliinien valmistamiseksiInfo
- Publication number
- FI103884B1 FI103884B1 FI934185A FI934185A FI103884B1 FI 103884 B1 FI103884 B1 FI 103884B1 FI 934185 A FI934185 A FI 934185A FI 934185 A FI934185 A FI 934185A FI 103884 B1 FI103884 B1 FI 103884B1
- Authority
- FI
- Finland
- Prior art keywords
- hydrogen
- guanidinocarbonyl
- preparation
- amino
- pharmaceutically effective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92116535 | 1992-09-28 | ||
| EP92116535 | 1992-09-28 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI934185A0 FI934185A0 (fi) | 1993-09-24 |
| FI934185A FI934185A (fi) | 1994-03-29 |
| FI103884B1 true FI103884B1 (fi) | 1999-10-15 |
| FI103884B FI103884B (fi) | 1999-10-15 |
Family
ID=8210063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI934185A FI103884B (fi) | 1992-09-28 | 1993-09-24 | Menetelmä farmaseuttisesti tehokkaiden guanidinokarbonyylisubstituoitujen isokinoliinien valmistamiseksi |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5416094A (fi) |
| EP (1) | EP0590455B1 (fi) |
| JP (1) | JP3645579B2 (fi) |
| AT (1) | ATE198328T1 (fi) |
| AU (1) | AU662079B2 (fi) |
| CA (1) | CA2107008C (fi) |
| DE (1) | DE69329787T2 (fi) |
| DK (1) | DK0590455T3 (fi) |
| ES (1) | ES2152938T3 (fi) |
| FI (1) | FI103884B (fi) |
| GR (1) | GR3035537T3 (fi) |
| HU (1) | HU218208B (fi) |
| IL (1) | IL107118A (fi) |
| NO (1) | NO180374C (fi) |
| NZ (1) | NZ248761A (fi) |
| PT (1) | PT590455E (fi) |
| TW (1) | TW272189B (fi) |
| ZA (1) | ZA937141B (fi) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4344550A1 (de) * | 1993-12-24 | 1995-06-29 | Hoechst Ag | Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen |
| DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4415873A1 (de) * | 1994-05-05 | 1995-11-09 | Hoechst Ag | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
| EP0863877A4 (en) * | 1995-10-19 | 1999-07-21 | Torrey Pines Inst | ISOCHINOLINE DERIVATIVES AND COMBINATONIC LIBRARIES OF ISOCHINOLINE |
| US5874443A (en) * | 1995-10-19 | 1999-02-23 | Trega Biosciences, Inc. | Isoquinoline derivatives and isoquinoline combinatorial libraries |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
| DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
| DE19548708A1 (de) * | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
| US20040122096A1 (en) * | 1996-06-03 | 2004-06-24 | Hoechst Aktiengesellschaft | Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids |
| US5916899A (en) * | 1996-10-18 | 1999-06-29 | Trega Biosciences, Inc. | Isoquinoline derivatives and isoquinoline combinatorial libraries |
| JP2002514192A (ja) * | 1996-11-13 | 2002-05-14 | セフアロン・インコーポレーテツド | ベンゾチアゾおよび関連の複素環基を含有するシステインおよびセリンプロテアーゼ阻害剤 |
| US5952328A (en) * | 1997-11-12 | 1999-09-14 | Cephalon, Inc. | Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| JP2002502414A (ja) * | 1997-06-02 | 2002-01-22 | 藤沢薬品工業株式会社 | 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体 |
| WO1999055679A1 (en) | 1998-04-28 | 1999-11-04 | Trega Biosciences, Inc. | Isoquinoline compound melanocortin receptor ligands and methods of using same |
| US6284735B1 (en) | 1998-04-28 | 2001-09-04 | Lion Bioscience Ag | HP-3228 and related peptides to treat sexual dysfunction |
| US6534503B1 (en) | 1998-04-28 | 2003-03-18 | Lion Bioscience Ag | Melanocortin receptor-3 ligands to treat sexual dysfunction |
| DE19859727A1 (de) * | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung |
| BRPI0519287A2 (pt) * | 2004-12-24 | 2009-01-06 | Astrazeneca Ab | derivados de amida |
| WO2007053610A2 (en) * | 2005-11-01 | 2007-05-10 | The Regents Of The University Of California | Methods of treating atrial fibrillation wtih pirfenidone |
| TW200800908A (en) * | 2006-02-15 | 2008-01-01 | Sanofi Aventis | Novel azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| CA2676066C (en) | 2007-01-22 | 2016-06-28 | Gtx, Inc. | Nuclear receptor binding agents |
| WO2018058109A1 (en) | 2016-09-26 | 2018-03-29 | Nusirt Sciences, Inc. | Compositions and methods for treating metabolic disorders |
| JP7378156B2 (ja) * | 2018-04-06 | 2023-11-13 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ | Ｋｅａｐ１／ｎｒｆ２タンパク質間相互作用の１，４－置換イソキノリン阻害剤 |
| KR102605163B1 (ko) * | 2021-06-01 | 2023-11-23 | 연세대학교 산학협력단 | 뇌암의 예방 또는 치료용 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
| DE2818423A1 (de) * | 1978-04-27 | 1979-11-08 | Hoechst Ag | Neue isochinolinderivate und verfahren zu ihrer herstellung |
| DE3013906A1 (de) * | 1980-04-11 | 1981-10-15 | C.H. Boehringer Sohn, 6507 Ingelheim | Substituierte (alpha) -aminocarbonyl-l-benzyl-3,4-dihydro-isochinoline, verfahren zu deren herstellung und deren verwendung |
| DE3233424A1 (de) * | 1982-09-09 | 1984-03-15 | Hoechst Ag, 6230 Frankfurt | Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
| JP2930399B2 (ja) * | 1990-10-18 | 1999-08-03 | 雪印乳業株式会社 | 新規イソキノリン誘導体またはその酸付加塩 |
-
1993
- 1993-09-20 AT AT93115081T patent/ATE198328T1/de not_active IP Right Cessation
- 1993-09-20 DE DE69329787T patent/DE69329787T2/de not_active Expired - Lifetime
- 1993-09-20 PT PT93115081T patent/PT590455E/pt unknown
- 1993-09-20 ES ES93115081T patent/ES2152938T3/es not_active Expired - Lifetime
- 1993-09-20 EP EP93115081A patent/EP0590455B1/en not_active Expired - Lifetime
- 1993-09-20 DK DK93115081T patent/DK0590455T3/da active
- 1993-09-24 NZ NZ248761A patent/NZ248761A/en unknown
- 1993-09-24 US US08/126,200 patent/US5416094A/en not_active Expired - Lifetime
- 1993-09-24 FI FI934185A patent/FI103884B/fi active
- 1993-09-27 NO NO933450A patent/NO180374C/no unknown
- 1993-09-27 AU AU48659/93A patent/AU662079B2/en not_active Ceased
- 1993-09-27 JP JP23996693A patent/JP3645579B2/ja not_active Expired - Fee Related
- 1993-09-27 ZA ZA937141A patent/ZA937141B/xx unknown
- 1993-09-27 CA CA002107008A patent/CA2107008C/en not_active Expired - Lifetime
- 1993-09-27 IL IL107118A patent/IL107118A/en not_active IP Right Cessation
- 1993-09-27 HU HU9302725A patent/HU218208B/hu not_active IP Right Cessation
- 1993-10-14 TW TW082108497A patent/TW272189B/zh active
-
2001
- 2001-03-09 GR GR20010400378T patent/GR3035537T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69329787T2 (de) | 2001-06-13 |
| DK0590455T3 (da) | 2001-01-22 |
| CA2107008A1 (en) | 1994-03-29 |
| HUT70149A (en) | 1995-09-28 |
| NO180374B (no) | 1996-12-30 |
| TW272189B (fi) | 1996-03-11 |
| AU4865993A (en) | 1994-04-14 |
| JP3645579B2 (ja) | 2005-05-11 |
| DE69329787D1 (de) | 2001-02-01 |
| NO933450L (no) | 1994-03-29 |
| NO933450D0 (no) | 1993-09-27 |
| PT590455E (pt) | 2001-04-30 |
| FI103884B (fi) | 1999-10-15 |
| JPH06211799A (ja) | 1994-08-02 |
| ATE198328T1 (de) | 2001-01-15 |
| IL107118A (en) | 1998-06-15 |
| HU9302725D0 (en) | 1993-12-28 |
| CA2107008C (en) | 2004-11-16 |
| NZ248761A (en) | 1995-04-27 |
| US5416094A (en) | 1995-05-16 |
| ES2152938T3 (es) | 2001-02-16 |
| AU662079B2 (en) | 1995-08-17 |
| NO180374C (no) | 1997-04-09 |
| FI934185A0 (fi) | 1993-09-24 |
| HU218208B (hu) | 2000-06-28 |
| GR3035537T3 (en) | 2001-06-29 |
| EP0590455A1 (en) | 1994-04-06 |
| FI934185A (fi) | 1994-03-29 |
| ZA937141B (en) | 1994-05-18 |
| IL107118A0 (en) | 1993-12-28 |
| EP0590455B1 (en) | 2000-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI103884B1 (fi) | Menetelmä farmaseuttisesti tehokkaiden guanidinokarbonyylisubstituoitujen isokinoliinien valmistamiseksi | |
| AU6358986A (en) | New quinazoline derivatives and a process for their production | |
| EP1035123A4 (en) | NEW HETEROCYCLIC COMPOUNDS | |
| EP0269574A3 (en) | Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient | |
| ES2000185A6 (es) | Procedimiento para preparar derivados de acidos piridoncaboxilicos | |
| HUT40101A (en) | Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents | |
| AU626740B2 (en) | Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments | |
| EP0370987A3 (en) | Pyrazine derivatives as medicaments for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals | |
| NO871575L (no) | Fremgangsmaate for fremstilling av 1,5-benztiazepin-derivater. | |
| DK0570850T3 (da) | Benzo(b)thiophen-3-yl-piperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler |